Endocrine abnormalities in morbid obesity.
Recognizing the hormonal changes that accompany morbid obesity may prevent inappropriate investigations and treatments as well as provide rational approaches to reducing the morbidity and mortality of this disorder. The secondary nature of some of these metabolic changes can be demonstrated by overfeeding nonobese subjects. The crucial role of achieving adequate weight loss is also emphasized by the reversal of most of the hormonal abnormalities following successful weight loss.
Peiris
A
A
Medical College of Wisconsin Clinical Research Center, Milwaukee.
Kissebah
A
A
D000305:Adrenal Cortex Hormones / Q000097:blood; D005260:Female; D005768:Gastrointestinal Hormones / Q000097:blood; D012739:Gonadal Steroid Hormones / Q000097:blood; D006728:Hormones / Q000097:blood*; D006801:Humans; D007028:Hypothalamic Hormones / Q000097:blood; D008297:Male; D009767:Obesity, Morbid / Q000097:blood*; D010187:Pancreatic Hormones / Q000097:blood; D010281:Parathyroid Hormone / Q000097:blood; D010907:Pituitary Hormones / Q000097:blood; D013963:Thyroid Hormones / Q000097:blood
D000305:Adrenal Cortex Hormones; D005768:Gastrointestinal Hormones; D012739:Gonadal Steroid Hormones; D006728:Hormones; D007028:Hypothalamic Hormones; D010187:Pancreatic Hormones; D010281:Parathyroid Hormone; D010907:Pituitary Hormones; D013963:Thyroid Hormones